Instil Bio Stock Performance
| TIL Stock | USD 19.09 1.09 5.40% |
The company retains a Market Volatility (i.e., Beta) of 0.29, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Instil Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Instil Bio is expected to be smaller as well. At this point, Instil Bio has a negative expected return of -0.37%. Please make sure to check out Instil Bio's value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if Instil Bio performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Instil Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in November 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
| Begin Period Cash Flow | 10.7 M | |
| Total Cashflows From Investing Activities | 54 M |
Instil Bio Relative Risk vs. Return Landscape
If you would invest 2,762 in Instil Bio on July 20, 2025 and sell it today you would lose (853.00) from holding Instil Bio or give up 30.88% of portfolio value over 90 days. Instil Bio is generating negative expected returns assuming volatility of 6.205% on return distribution over 90 days investment horizon. In other words, 55% of stocks are less volatile than Instil, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Instil Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Instil Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Instil Bio, and traders can use it to determine the average amount a Instil Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0603
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TIL |
Estimated Market Risk
| 6.21 actual daily | 55 55% of assets are less volatile |
Expected Return
| -0.37 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Instil Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Instil Bio by adding Instil Bio to a well-diversified portfolio.
Instil Bio Fundamentals Growth
Instil Stock prices reflect investors' perceptions of the future prospects and financial health of Instil Bio, and Instil Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Instil Stock performance.
| Return On Equity | -0.52 | |||
| Return On Asset | -0.13 | |||
| Current Valuation | 111.53 M | |||
| Shares Outstanding | 6.75 M | |||
| Price To Earning | 18.31 X | |||
| Price To Book | 0.90 X | |||
| Price To Sales | 55,330 X | |||
| EBITDA | (61.53 M) | |||
| Cash And Equivalents | 354.61 M | |||
| Cash Per Share | 2.73 X | |||
| Total Debt | 86.89 M | |||
| Debt To Equity | 0.12 % | |||
| Book Value Per Share | 19.50 X | |||
| Cash Flow From Operations | (55.7 M) | |||
| Earnings Per Share | (12.91) X | |||
| Total Asset | 263.57 M | |||
| Retained Earnings | (655.12 M) | |||
About Instil Bio Performance
By examining Instil Bio's fundamental ratios, stakeholders can obtain critical insights into Instil Bio's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Instil Bio is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company was incorporated in 2018 and is headquartered in Dallas, Texas. Instil Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 463 people.Things to note about Instil Bio performance evaluation
Checking the ongoing alerts about Instil Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Instil Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Instil Bio generated a negative expected return over the last 90 days | |
| Instil Bio has high historical volatility and very poor performance | |
| Instil Bio has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (74.14 M) with profit before taxes, overhead, and interest of 138 K. | |
| Instil Bio has about 354.61 M in cash with (55.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.73. | |
| Roughly 69.0% of the company shares are owned by institutional investors |
- Analyzing Instil Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Instil Bio's stock is overvalued or undervalued compared to its peers.
- Examining Instil Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Instil Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Instil Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Instil Bio's stock. These opinions can provide insight into Instil Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.